Facebook Linkedin RSS Twitter Youtube
Home 2024

Clinical drug development

Another Phase III Trial Failure in Neuroscience: What Are We Doing Wrong?
Drug Discovery

Another Phase III Trial Failure in Neuroscience: What Are We Doing Wrong?

FDA Approves Pfizer’s One-Time Gene Therapy BEQVEZ for Hemophilia B
Drug Discovery

FDA Approves Pfizer’s One-Time Gene Therapy BEQVEZ for Hemophilia B

StockWatch: Biogen Q1 Results Beat Expectations, for a Change
Drug Discovery

StockWatch: Biogen Q1 Results Beat Expectations, for a Change

Insilico Targets MTAP Deleted Cancers with AI-Designed Candidate
Artificial Intelligence

Insilico Targets MTAP Deleted Cancers with AI-Designed Candidate

Dendritic Cell Vaccine Improves Survival Compared to Standard of Care in Phase I Trial for Glioblastoma
Cancer

Dendritic Cell Vaccine Improves Survival Compared to Standard of Care in Phase I Trial for Glioblastoma

Vaccines in Development
Infectious Diseases

Vaccines in Development

REGENXBIO and AbbVie Advance Wet AMD Gene Therapy to Phase III
Drug Discovery

REGENXBIO and AbbVie Advance Wet AMD Gene Therapy to Phase III

Evotec Expands Anti-HIV Antibody Deal with Advanced BioScience Laboratories
Bioprocessing

Evotec Expands Anti-HIV Antibody Deal with Advanced BioScience Laboratories

Psychedelics Coming into the Modern Age of Medicine
Insights

Psychedelics Coming into the Modern Age of Medicine

Light My Fire: COUR Raises $105M Series A to Advance Tolerogenic Nanoparticles for Autoimmunity
Drug Discovery

Light My Fire: COUR Raises $105M Series A to Advance Tolerogenic Nanoparticles for Autoimmunity

1234...206Page 3 of 206
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.